Gelesis
IPOBoston, United States · $154.0M raised
- Headquarters
- Boston, Massachusetts
- Business Model
- B2B
- Website
- gelesis.com
- Total Funding
- $154.0M
- Last Round
- $84.0M Series DJan 2021
- Rounds
- 4
About
Italian biotech developing hydrogel-based medical devices for weight management and GI-related conditions.
Summary
Gelesis is a Biotech company based in Boston, United States. It has raised $154.0M in total across 4 rounds, most recently a $84.0M Series D round in Jan 2021. Investors include PureTech Health, OrbiMed and Vitruvian Partners.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2022
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...